Fact CheckerSign in

NCT06050850Not yet recruiting

Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL

A Healthy Weight Intervention for Family Stress During the Early Phases of ALL Treatment: NOURISH-ALL

Source: ClinicalTrials.gov · Last updated 8 Jul 2026

Brief summary (registry, in English)

The purpose of this study is to conduct a single arm pilot of the NOURISH-ALL (Nourishing Our Understanding of Role modeling to Improve Support and Health in Acute Lymphoblastic Leukemia) intervention focused on three components of participant engagement. This is a single arm intervention study that involves participation in a 6-session family intervention and three time points of multimethod data collection. The primary outcome is participant engagement, measured as recruitment, retention, and intended dose received. This study will be conducted over 5 years in three phases: * Aim 1a: Adapting the NOURISH-ALL Intervention for Families of Youth with ALL (Year 1) * Aim 1b: Iteratively Refining the NOURISH-ALL Intervention (Year 2) * Aim 2: Pilot Single-Arm Trial of NOURISH-ALL Focused on Participant Engagement (Years 3-5)

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
8 Sept 2023
Start date
1 Sept 2026
Primary completion date
1 Sept 2028
Lead sponsor
University of Kansas Medical Center
NCT number
NCT06050850

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 1 Sept 2026 to the primary completion date, 1 Sept 2028
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Primary oncology provider identifies safety concerns regarding the child's participation in the study.

Who the study is looking for

  • Children ages 2-12 years old and their primary caregiver ages 18-90
  • Child diagnosed with acute lymphoblastic leukemia (ALL)
  • Child completed induction phase of therapy and not yet in maintenance phase of therapy
  • Primary caregiver and child English language proficient
  • Primary caregiver able to provide permission for child to participate in research
  • Primary caregiver identifies as being involved with child's oncology care
  • Primary caregiver lives with child at least 50% of the time
  • Primary oncology provider confirms child is eligible to participate

Age in the registry: 2 years to 12 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Kansas Medical Center
Coordinator of this site? Confirm its status
Kansas CityUnited StatesUnknown status
Children's Mercy Kansas City
Coordinator of this site? Confirm its status
Kansas CityUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.